Literature DB >> 20305538

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Anthony J Gill1, Angela Chou, Ricardo Vilain, Adele Clarkson, Millie Lui, Richard Jin, Vivienne Tobias, Jaswinder Samra, David Goldstein, Celia Smith, Loretta Sioson, Nicole Parker, Ross C Smith, Mark Sywak, Stan B Sidhu, Jenny Ma Wyatt, Bruce G Robinson, Robert P Eckstein, Diana E Benn, Roderick J Clifton-Bligh.   

Abstract

The Carney triad (CT) is gastrointestinal stromal tumor (GIST), paraganglioma, and pulmonary chondroma. The GISTs of CT show different clinical, molecular, and morphologic features to usual adult GISTs but are similar to the majority of pediatric GISTs. We postulated that these GISTs would show negative staining for succinate dehydrogenase B (SDHB). We performed SDHB immunohistochemistry on GISTs arising in 5 individuals with CT, 1 child, 7 individuals with GIST in young adulthood including 2 with germline KIT mutations, 3 individuals with neurofibromatosis 1, one 63-year-old female with multifocal gastric epithelioid GIST with lymph node metastases, and 104 consecutive unselected individuals with apparently sporadic GIST. The GISTs and paragangliomas arising in CT, the pediatric GIST, and the multifocal gastric GIST from the 63-year-old showed negative SDHB staining. GISTs from the 7 young adults and 3 with neurofibromatosis were SDHB positive. Of the unselected GISTs, 101 (97%) were positive. One of the negative GISTs arose in a 48-year-old female with previous recurrent multifocal gastric GISTs and the other 2 arose in females also in their 40s with gastric GISTs with epithelioid morphology. We conclude that negative staining for SDHB is characteristic of the GISTs of CT and the subgroup of pediatric GISTs which it resembles. Furthermore, when negative staining occurs in apparently sporadic GISTs in adults, the GISTs show morphologic and clinical features similar to pediatric and CT type GISTs. GISTs may therefore be divided into type 1 (SDHB positive) and type 2 (SDHB negative) subtypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305538     DOI: 10.1097/PAS.0b013e3181d6150d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  70 in total

1.  Carney Stratakis syndrome in a patient with SDHD mutation.

Authors:  Carmen Tenorio Jiménez; Louise Izatt; Fuju Chang; Mufaddal T Moonim; Paul V Carroll; Barbara M McGowan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

3.  SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.

Authors:  José Gaal; Constantine A Stratakis; J Aidan Carney; Evan R Ball; Esther Korpershoek; Maya B Lodish; Isaac Levy; Paraskevi Xekouki; Francien H van Nederveen; Michael A den Bakker; Maureen O'Sullivan; Winand N M Dinjens; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2010-10-01       Impact factor: 7.842

Review 4.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

5.  A unique model for SDH-deficient GIST: an endocrine-related cancer.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Xue Zhang; Inna Lomakin; Troy Langford; Kassi Taylor Stein; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2018-07-02       Impact factor: 5.678

Review 6.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

7.  Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.

Authors:  Kristine M Cornejo; Min Lu; Ping Yang; Shulin Wu; Chao Cai; Wei-de Zhong; Aria Olumi; Robert H Young; Chin-Lee Wu
Journal:  Hum Pathol       Date:  2015-03-11       Impact factor: 3.466

8.  Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.

Authors:  Esmeralda Castelblanco; Maria Santacana; Joan Valls; Aguirre de Cubas; Alberto Cascón; Mercedes Robledo; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

9.  Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Authors:  Markku Miettinen; Maarit Sarlomo-Rikala; Peter McCue; Piotr Czapiewski; Renata Langfort; Piotr Waloszczyk; Krzysztof Wazny; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

10.  Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.

Authors:  Maria A Pantaleo; Annalisa Astolfi; Milena Urbini; Margherita Nannini; Paola Paterini; Valentina Indio; Maristella Saponara; Serena Formica; Claudio Ceccarelli; Rita Casadio; Giulio Rossi; Federica Bertolini; Donatella Santini; Maria G Pirini; Michelangelo Fiorentino; Umberto Basso; Guido Biasco
Journal:  Eur J Hum Genet       Date:  2013-04-24       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.